Department of Neurological Surgery, Montefiore Medical Center, Bronx, NY, USA.
Department of Neurological Surgery, Weill Cornell Medicine, New York, NY, USA.
Interv Neuroradiol. 2022 Apr;28(2):219-228. doi: 10.1177/15910199211025917. Epub 2021 Jun 14.
Flow diversion is an effective treatment modality for intracranial aneurysms but is associated with ischemic and hemorrhagic complications. Patients treated with flow diversion require dual antiplatelet therapy and subsequent platelet function tests. At our institution, Thromboelastography with Platelet Mapping (TEG-PM) is the test of choice. The primary objective of this study was to identify TEG parameters that are predictive of postoperative complications in patients treated with elective flow diversion.
This was a retrospective study of 118 patients with unruptured intracranial aneurysms treated with flow diversion. Data was collected via chart review. Bivariate analyses were performed to identify significant variables in patients who suffered an ischemic stroke or a groin hematoma. ROC curves were constructed for the TEG parameters with statistical significance. Bivariate analyses were repeated using dichotomized TEG results.
Patients who experienced a symptomatic ischemic stroke had a history of stroke (p value = 0.007), larger aneurysm neck width (p value = 0.017), and a higher alpha angle (p value = 0.013). Cut off point for ischemic complication is 63° on ROC curve with a sensitivity of 100% and specificity of 65%. Patients who experienced a groin hematoma were no different from their healthy peers but had a lower alpha angle (p value = 0.033). Cut off point for hemorrhagic complication is 53.3° with a sensitivity of 82% and specificity of 67%.
The Alpha Angle parameter of TEG-PM has a sizeable predictive ability for both ischemic complications of the central nervous system and hemorrhagic complications of the access site after elective flow diversion.
血流导向装置是治疗颅内动脉瘤的有效方法,但与缺血性和出血性并发症有关。接受血流导向装置治疗的患者需要接受双重抗血小板治疗和随后的血小板功能检测。在我们的机构中,血栓弹力图伴血小板图(TEG-PM)是首选的检测方法。本研究的主要目的是确定可预测接受择期血流导向装置治疗的患者术后并发症的 TEG 参数。
这是一项回顾性研究,共纳入 118 例接受血流导向装置治疗的未破裂颅内动脉瘤患者。通过病历回顾收集数据。进行双变量分析以确定发生缺血性卒中和腹股沟血肿的患者中的显著变量。对具有统计学意义的 TEG 参数绘制 ROC 曲线。使用二分类 TEG 结果重复进行双变量分析。
发生症状性缺血性卒中的患者有卒中病史(p 值=0.007)、更大的动脉瘤颈宽度(p 值=0.017)和更高的α角(p 值=0.013)。ROC 曲线的缺血性并发症截断点为 63°,敏感性为 100%,特异性为 65%。发生腹股沟血肿的患者与健康对照组无差异,但α角较低(p 值=0.033)。出血性并发症的截断点为 53.3°,敏感性为 82%,特异性为 67%。
TEG-PM 的α角参数对择期血流导向装置治疗后中枢神经系统缺血性并发症和入路部位出血性并发症均具有较大的预测能力。